{"schema_version":"secwatch.filing_event.v1","accession":"0001773751-26-000010","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.131691+00:00","generated_at":"2026-05-16T01:47:39.083565+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Hims & Hers acquires Eucalyptus for up to $1.15B, expanding globally","bullets":["Transaction valued up to $1.15B: ~$240M cash upfront, ~$710M deferred over 18 months, up to ~$200M earnouts.","Eucalyptus has ARR >$450M, triple-digit YoY growth in 2025, and served >775,000 customers.","Tim Doyle, Eucalyptus CEO, to become SVP of International at Hims & Hers post-close.","Acquisition expected to close mid-2026, subject to regulatory approvals and customary conditions.","Hims & Hers to finance with existing cash and US operating cash flows; option to settle payments in stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001773751-26-000010","json":"https://secwatch.observer/filing/0001773751-26-000010.json","markdown":"https://secwatch.observer/filing/0001773751-26-000010.md","text":"https://secwatch.observer/filing/0001773751-26-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000010/0001773751-26-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000010/hims-20260219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:47:39.083565+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"41be816842d6e1cc0061c6906e285a86e93bf3af","claim":"Hims & Hers Health, Inc. entered into Securities Sale Deed with the sellers party thereto valued at up to approximately $1,150,000,000 (effective 2026-02-19).","evidence_excerpt":"On February 19, 2026, Hims & Hers Health, Inc. (the “ Company ”), Hims, Inc. (the “ Guarantor ”), and Horizon BidCo Pty Ltd ACN 694 778 375, an Australian proprietary company (the “ Purchaser ”) and wholly-owned subsidiary of the Company, entered into a Securities Sale Deed (the “ Deed ”) with the sellers party thereto (the “ Sellers ”), pursuant to which, among other things, the Sellers agreed to sell and Purchaser agreed to purchase from each Seller (the “ Proposed Acquisition ”) all of the issued capital (the “ Target Equity ”) of EUC Management Pty Ltd ACN 631 013 860 (d/b/a Eucalyptus) (the “ Target ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000010/0001773751-26-000010-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"the sellers party thereto"},{"label":"Value","value":"up to approximately $1,150,000,000"},{"label":"Effective","value":"2026-02-19"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}